Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia. 1999

H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
Departments of Pathology, Endocrinology, Nephrology, Endocrine Surgery, and the Epidemiological Research Center, Toranomon Hospital, Minatoko, Japan. hiroshi.matsushita@toranomon.gr.jp

BACKGROUND Parathyroid hormone-related protein (PTHrP) is now suspected to act as an autocrine or paracrine regulator of cell growth or differentiation, although it was originally reported as a hypercalcemic substance in malignancies. This study was performed to assess the relationship between PTHrP expression and cell proliferation in human parathyroid glands. METHODS The localization of PTH and PTHrP was studied in 42 samples of hyperplastic parathyroid from 14 long-term hemodialysis cases with immunohistochemistry and in situ hybridization. Results were compared with proliferative activity (proliferating cell nuclear antigen index: counts of proliferating cell nuclear antigen-positive cells/100 cells). The localization of the PTH/PTHrP receptor was also examined. Ten normal glands were studied as controls. RESULTS In hyperplasia, cells positive for PTH, PTHrP, or both were observed immunohistochemically. The areas expressing PTHrP mRNA completely coincided with those positive for PTHrP immunohistochemically. Oxyphilic or transitional oxyphilic cells were consistently positive for PTHrP. PTH/PTHrP receptors were located in the cytoplasmic membrane in most parathyroid cells. Proliferating cell nuclear antigen-positive cells were rare in normal glands with an index of 0. 22 +/- 0.09 (mean +/- sem). They were significantly increased in hyperplastic cases but less for PTHrP-positive than for -negative cells (1.25 +/- 0.16 as compared with 7.80 +/- 0.52; P < 0.0001). CONCLUSIONS The observed low level of proliferation of PTHrP-positive cells suggests a functional role for PTHrP as a possible growth suppressor in the human parathyroid.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females

Related Publications

H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
April 1990, The New England journal of medicine,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
October 1999, Endocrine journal,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
February 1999, Journal of anatomy,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
January 1998, Journal of cardiovascular pharmacology,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
March 2002, Chest,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
May 1990, The Journal of pathology,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
March 1994, Cancer,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
December 1996, Human pathology,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
January 1996, Journal of cellular physiology,
H Matsushita, and M Hara, and Y Endo, and Y Shishiba, and S Hara, and Y Ubara, and H Nakazawa, and N Suzuki, and K Kawaminami, and T Kido, and Q Li, and L Grimelius
December 2005, The Tokai journal of experimental and clinical medicine,
Copied contents to your clipboard!